T1	Intervention 588 698	10 to 600 mg once daily and 50 and 300 mg twice daily were evaluated in 15- and 28-day multiple-dosing cohorts
T2	Intervention 182 208	inhibitors of cathepsin K,
T3	Intervention 443 451	ONO-5334
T4	Intervention 811 871	15-day multiple-dose cohort, 100, 300, and 600 mg once daily
T5	Intervention 1239 1247	ONO-5334
T6	Intervention 1324 1360	Multiple dosing with ONO-5334 100 mg
